216 related articles for article (PubMed ID: 19874621)
1. Wnt pathway reprogramming during human embryonal carcinoma differentiation and potential for therapeutic targeting.
Snow GE; Kasper AC; Busch AM; Schwarz E; Ewings KE; Bee T; Spinella MJ; Dmitrovsky E; Freemantle SJ
BMC Cancer; 2009 Oct; 9():383. PubMed ID: 19874621
[TBL] [Abstract][Full Text] [Related]
2. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.
Maerz WJ; Baselga J; Reuter VE; Mellado B; Myers ML; Bosl GJ; Spinella MJ; Dmitrovsky E
Oncogene; 1998 Aug; 17(6):761-7. PubMed ID: 9715278
[TBL] [Abstract][Full Text] [Related]
3. Expression of Wnt and Notch pathway genes in a pluripotent human embryonal carcinoma cell line and embryonic stem cell.
Walsh J; Andrews PW
APMIS; 2003 Jan; 111(1):197-210; discussion 210-1. PubMed ID: 12760378
[TBL] [Abstract][Full Text] [Related]
4. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells.
Spinella MJ; Kitareewan S; Mellado B; Sekula D; Khoo KS; Dmitrovsky E
Oncogene; 1998 Jul; 16(26):3471-80. PubMed ID: 9692555
[TBL] [Abstract][Full Text] [Related]
5. Human Wnt-13 is developmentally regulated during the differentiation of NTERA-2 pluripotent human embryonal carcinoma cells.
Wakeman JA; Walsh J; Andrews PW
Oncogene; 1998 Jul; 17(2):179-86. PubMed ID: 9674702
[TBL] [Abstract][Full Text] [Related]
6. 4HPR triggers apoptosis but not differentiation in retinoid sensitive and resistant human embryonal carcinoma cells through an RARgamma independent pathway.
Kitareewan S; Spinella MJ; Allopenna J; Reczek PR; Dmitrovsky E
Oncogene; 1999 Oct; 18(42):5747-55. PubMed ID: 10523855
[TBL] [Abstract][Full Text] [Related]
7. Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity.
Giuliano CJ; Kerley-Hamilton JS; Bee T; Freemantle SJ; Manickaratnam R; Dmitrovsky E; Spinella MJ
Biochim Biophys Acta; 2005 Oct; 1731(1):48-56. PubMed ID: 16168501
[TBL] [Abstract][Full Text] [Related]
8. The miR-134 attenuates the expression of transcription factor FOXM1 during pluripotent NT2/D1 embryonal carcinoma cell differentiation.
Chen Y; Meng L; Yu Q; Dong D; Tan G; Huang X; Tan Y
Exp Cell Res; 2015 Jan; 330(2):442-450. PubMed ID: 25447206
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of human embryonal carcinomas in vitro and in vivo reveals expression profiles relevant to normal development.
Skotheim RI; Lind GE; Monni O; Nesland JM; Abeler VM; Fosså SD; Duale N; Brunborg G; Kallioniemi O; Andrews PW; Lothe RA
Cancer Res; 2005 Jul; 65(13):5588-98. PubMed ID: 15994931
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function.
Curtin JC; Dragnev KH; Sekula D; Christie AJ; Dmitrovsky E; Spinella MJ
Oncogene; 2001 May; 20(20):2559-69. PubMed ID: 11420666
[TBL] [Abstract][Full Text] [Related]
11. Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation.
Biswal BK; Beyrouthy MJ; Hever-Jardine MP; Armstrong D; Tomlinson CR; Christensen BC; Marsit CJ; Spinella MJ
PLoS One; 2012; 7(12):e53003. PubMed ID: 23300844
[TBL] [Abstract][Full Text] [Related]
12. Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells.
Chadalavada RS; Korkola JE; Houldsworth J; Olshen AB; Bosl GJ; Studer L; Chaganti RS
Stem Cells; 2007 Mar; 25(3):771-8. PubMed ID: 17138961
[TBL] [Abstract][Full Text] [Related]
13. Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells.
Yuzugullu H; Benhaj K; Ozturk N; Senturk S; Celik E; Toylu A; Tasdemir N; Yilmaz M; Erdal E; Akcali KC; Atabey N; Ozturk M
Mol Cancer; 2009 Oct; 8():90. PubMed ID: 19849855
[TBL] [Abstract][Full Text] [Related]
14. Role of retinoic acid in the differentiation of embryonal carcinoma and embryonic stem cells.
Soprano DR; Teets BW; Soprano KJ
Vitam Horm; 2007; 75():69-95. PubMed ID: 17368312
[TBL] [Abstract][Full Text] [Related]
15. p53 in human embryonal carcinoma: identification of a transferable, transcriptional repression domain in the N-terminal region of p53.
Curtin JC; Spinella MJ
Oncogene; 2005 Feb; 24(9):1481-90. PubMed ID: 15674351
[TBL] [Abstract][Full Text] [Related]
16. Expression and roles of system L amino acid transporters in human embryonal carcinoma cells.
Chatsirisupachai K; Kitdumrongthum S; Panvongsa W; Janpipatkul K; Worakitchanon W; Lertjintanakit S; Wongtrakoongate P; Chairoungdua A
Andrology; 2020 Nov; 8(6):1844-1858. PubMed ID: 32741077
[TBL] [Abstract][Full Text] [Related]
17. Transforming pluripotency: an exon-level study of malignancy-specific transcripts in human embryonal carcinoma and embryonic stem cells.
Alagaratnam S; Harrison N; Bakken AC; Hoff AM; Jones M; Sveen A; Moore HD; Andrews PW; Lothe RA; Skotheim RI
Stem Cells Dev; 2013 Apr; 22(7):1136-46. PubMed ID: 23137282
[TBL] [Abstract][Full Text] [Related]
18. Developmentally-related candidate retinoic acid target genes regulated early during neuronal differentiation of human embryonal carcinoma.
Freemantle SJ; Kerley JS; Olsen SL; Gross RH; Spinella MJ
Oncogene; 2002 Apr; 21(18):2880-9. PubMed ID: 11973648
[TBL] [Abstract][Full Text] [Related]
19. Role of SOX2 in the etiology of embryonal carcinoma, based on analysis of the NCCIT and NT2 cell lines.
Eini R; Stoop H; Gillis AJ; Biermann K; Dorssers LC; Looijenga LH
PLoS One; 2014; 9(1):e83585. PubMed ID: 24404135
[TBL] [Abstract][Full Text] [Related]
20. Derivation and characterization of retinoid-resistant human embryonal carcinoma cells.
Moasser MM; Khoo KS; Maerz WJ; Zelenetz A; Dmitrovsky E
Differentiation; 1996 Jul; 60(4):251-7. PubMed ID: 8765055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]